The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.61, representing a +1.88% change from its previous close.

Yet, I assess that Viking Therapeutics’s main growth vector will likely be imputed to its ability to commercialize and ...

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...

Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

That said, the reaction with Viking stock seems a bit overdone, especially given that Novo Nordisk is quite a storied enterprise that will likely take care in replacing its CEO. Viking investors ...

AMGN and VKTX’s products can pose strong competition ... as seen in the chart below. The stock is currently trading below both its 50 and 200-day moving averages. Novo Nordisk is trading at ...